drugset / Trial / NCT01867866
Study Comparing the Pharmacokinetics of FTD as a Component of TAS-102 With FTD Alone
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to compare the pharmacokinetics of trifluorothymidine (FTD) as a component of TAS-102 with FTD alone.
Timeline
- Start
- 2013-05
- Primary completion
- 2013-10
- Completion
- 2016-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | TAS-102 | Small molecule | 35 mg/m2 | Oral |
| Subject | Trifluridine | Small molecule | 35 mg/m2 | Oral |